Research Article
CRISPR-Cas9 Gene Editing and Its Applications: Treating Genetic Disorders, Improving Crop Yields, and Addressing Antibiotic Resistance
Roqayah H. AlQaraawee, Lamyaa Hussein Mousa Mazene, Haidar Ali Alsalmani
Middle East Research Journal of Biological Sciences; 36-43.
https://doi.org/10.36348/merjbs.2025.v05i02.001
The revolutionary gene-editing technique known as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) have numerous uses on biomedicine and agriculture. CRISPR-Cas9 was first identified in prokaryotes as an adaptive immune system, but it has now developed into a potent instrument for accurate genome alteration. The mechanisms of action of CRISPR-Cas9, possible uses for treating genetic abnormalities, increasing crop yields and stress tolerance, and combating antibiotic resistance worldwide are all examined in this study. In terms of methodology, this study collects information from current clinical trials, experimental research, and agricultural field applications.
The results demonstrate notable progress in improving crop drought tolerance, treating hematologic disorders including sickle cell anemia, and re-sensitizing antibiotic-resistant bacterial strains. Even with these developments, issues with equitable access, off-target impacts, and moral conundrums still exist. The topic of discussion is striking a balance between safety and innovation in order to optimize CRISPR's worldwide influence. Because CRISPR-Cas9 gene editing provides accurate and effective methods for changing DNA sequences, it is transforming a number of industries, including biotechnology, agriculture, and medicine. The application of CRISPR-Cas9 to heal genetic disorders, increase crop yields, and fight antibiotic resistance will be examined in this essay.
Review Article
Oxidative Stress, Inflammation and Diseases that Induced by Cigarette Smoke Toxicity
Safa Mohammed Diya, Emam Atiyah Ibadi
Middle East Research Journal of Biological Sciences; 44-54.
https://doi.org/10.36348/merjbs.2025.v05i02.002
Smoking is a global public health crisis driven by highly addictive nicotine. These chemical hijacks the brain's reward system, fueling intense cravings and making cessation extremely difficult. The outcome is devastating: tobacco kills up to half its regular users, causing over 7 million annual deaths, which tragically includes 1.6 million non-smokers exposed to second-hand smoke. The toxicity stems from the smoke's staggering chemical complexity, featuring over 7,000 constituents. Crucially, sidestream smoke from the burning tip comprises 85% of the mixture and carries a higher concentration of toxic gases than inhaled mainstream smoke. The core mechanism of damage is a destructive cycle of oxidative stress and chronic inflammation. Smoking triggers an excessive production of free radicals that overwhelm the body's defenses, severely damaging cellular molecules like DNA and proteins. This pathological state immediately induces proinflammatory effects, leading to chronic, destructive inflammation. This cumulative damage is the foundation for smoking's broad disease spectrum. Tobacco use is the primary cause of lung cancer and is definitively linked to 25% of all global cancer deaths. It is also a major risk factor for heart disease, stroke, COPD, and Type 2 Diabetes. This addictive practice significantly drives global mortality and imposes massive economic and healthcare burdens worldwide. This review aim to elucidate the pathological mechanisms by which cigarette smoke toxicity is mediated through oxidative stress and chronic inflammation, and to discuss the resultant range of associated diseases and their public health impact.
This work is licensed under a Creative Commons
Attribution-NonCommercial 4.0 International License.
© Copyright Kuwait Scholars Publisher. All Rights Reserved.